Delivery Order SPE2DE24DA017-SPE2D625F0W54

Award Date 3/3/25
Potential Completion Date 3/6/25
Potential Value $16K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, by the Defense Logistics Agency (DLA). The contract is for the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized orthopedic product. The fixed-price contract with economic price adjustment has a ceiling value of $1,514.70 and a period of performance through September 10, 2024. Arthrex, a for-profit Subchapter S Corporation based in Naples, Florida, has received...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,584.00, is a Fixed Price Delivery Order with Economic Price Adjustment for the purchase of the ACP MAX PRP SYSTEM (OUS/EU). This award is not associated with a set-aside program. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the delivery of the ARTHREX ACP DOUBLE SYRINGE SYSTEM, a specialized medical device. The fixed-price contract with economic price adjustment has a ceiling value of $1,650.00 and a performance period ending on February 27, 2025. Arthrex Inc. is a for-profit Subchapter S...
This is a federal contract award from the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the delivery of the ARTHREX ACP DOUBLE SYRINGE SYSTEM, a specialized medical device, with a ceiling value of $4,950. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of January 21, 2025. Arthrex Inc. is a...
This is a fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract has a ceiling value of $1,650.00 and an ultimate completion date of January 13, 2025. This contract is not designated as a set-aside. Arthrex Inc. is a for-profit...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,514.70, is for the delivery of the "4566415286 ! ACP MAX PRP SYSTEM (W/ ACDA)" product. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and an Ultimate Completion Date of November 18, 2024. This contract award is not...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $3,633.30, is a Delivery Order for an "ACP MAX PRP SYSTEM (W/ ACDA)" and has a fixed price with economic price adjustment pricing type. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 9, 2025. The contract was not designated as a...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $3,960.00 fixed-price delivery order with economic price adjustment is for the ACP MAX PRP (Platelet-Rich Plasma) System for use overseas and in the European Union. This order falls under Arthrex's larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the DLA, which enables VA medical centers...
This is a federal delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a for-profit Subchapter S Corporation headquartered in Naples, Florida. The contract is for the procurement of the Arthrex ACP Double Syringe System, a specialized orthopedic medical device. The fixed-price with economic price adjustment contract has a ceiling value of $11,550.00 and an ultimate completion date of January 22, 2025. This delivery order is issued under...
This is a federal delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $23,436.00, is for the provision of the ACP MAX PRP SYSTEM (OUS/EU) medical product. The contract is a Fixed Price with Economic Price Adjustment type, and has an ultimate completion date of January 22, 2025. Arthrex Inc., a for-profit Subchapter S Corporation, is the prime...
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F0W54
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the ACP MAX PRP SYSTEM (OUS/EU), a medical device used in orthopedic procedures, with a ceiling value of $15,759.00. The contract is a Fixed Price with Economic Price Adjustment, with a period of performance through March 6, 2025.

Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The company specializes in developing, manufacturing, and supplying advanced orthopedic products, surgical implants, instruments, and biologics for medical professionals and healthcare systems, with a focus on serving the Department of Veterans Affairs (VA) and the Department of Defense (DoD). This contract is not a set-aside, indicating Arthrex's strong competitive position in the federal marketplace. Arthrex also holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $471,048,172.66, which allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders.

Generated 6/2/25, 9:54 AM